Literature DB >> 2822993

Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremia.

J Merke1, U Hügel, A Zlotkowski, A Szabó, J Bommer, G Mall, E Ritz.   

Abstract

In Sprague Dawley rats, six days after subtotal nephrectomy, serum 1,25(OH)2D3 concentration was diminished (59.8 +/- 17.5 pg/ml vs. 121 +/- 48; P less than 0.01). Despite low circulating 1,25(OH)2D3 levels, maximal specific binding capacity for 1,25(OH)2D3 in parathyroid glands was diminished (Nmax 87.5 fmol/mg protein and 3.52 fmol/mg DNA vs. 143 fmol/mg protein and 4.75 fmol/mg DNA, respectively). There was no change of KD, apparent molecular size (sucrose density gradient) and DNA binding affinity (DNA cellulose chromatography) pointing to intactness of the receptor. Since 1,25(OH)2D3 is a potent negative feedback signal for parathyroids, the data are potentially relevant for the genesis of secondary renal hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822993     DOI: 10.1038/ki.1987.216

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Vitamin D and its analogs in chronic renal failure.

Authors:  E Slatopolsky; A J Brown
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  FGF23 fails to inhibit uremic parathyroid glands.

Authors:  Rocío Canalejo; Antonio Canalejo; Julio Manuel Martinez-Moreno; M Encarnacion Rodriguez-Ortiz; Jose C Estepa; Francisco Javier Mendoza; Juan Rafael Munoz-Castaneda; Victoria Shalhoub; Yolanda Almaden; Mariano Rodriguez
Journal:  J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 10.121

3.  Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat.

Authors:  T Naveh-Many; J Silver
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.

Authors:  Jane L Finch; Masanori Tokumoto; Hironori Nakamura; Wei Yao; Mohammad Shahnazari; Nancy Lane; Eduardo Slatopolsky
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-03

5.  Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries.

Authors:  J Merke; P Milde; S Lewicka; U Hügel; G Klaus; D J Mangelsdorf; M R Haussler; E W Rauterberg; E Ritz
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

6.  Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.

Authors:  J A Delmez; C Tindira; P Grooms; A Dusso; D W Windus; E Slatopolsky
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

7.  Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

Authors:  N Fukuda; H Tanaka; Y Tominaga; M Fukagawa; K Kurokawa; Y Seino
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Calcitriol effect on natural killer cells from hemodialyzed and normal subjects.

Authors:  J M Quesada; I Serrano; F Borrego; A Martin; J Peña; R Solana
Journal:  Calcif Tissue Int       Date:  1995-02       Impact factor: 4.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.